Table 3. Association of DNA hypermethylationed ABCG1, GALNT2 and HMGCR genes with clinic characteristics.
Characteristics | ABCG1 | GALNT2 | HMGCR | |||||||||
U | M | P-value | P-value* | U | M | P-value | P-value* | U | M | P-value | P-value* | |
(Mean ± s.e.) | (Mean ± s.e.) | (Mean ± s.e.) | (Mean ± s.e.) | (Mean ± s.e.) | (Mean ± s.e.) | |||||||
Age(yrs) | 57.28±10.01 | 60.44±9.05 | O.O66 | 0.651 | 57.28±9.87 | 62.10±8.21 | 0.004 | 0.008 | 57.79±9.55 | 63.24±8.10 | 0.003 | 0.014 |
Gender (M/F) | 25/21 | 63/30 | 0.125 | 0.423 | 48/30 | 40/21 | 0.624 | 0.971 | 62/26 | 36/15 | 0.987 | 0.139 |
Smoking(Y/N) | 17/29 | 47/46 | 0.132 | 0.819 | 34/44 | 30/31 | 0.512 | 0.522 | 50/48 | 14/27 | 0.071 | 0.033 |
Hypertension(Y/N) | 21/25 | 58/35 | 0.063 | 0.413 | 42/36 | 37/24 | 0.422 | 0.897 | 55/43 | 24/17 | 0.793 | 0.315 |
Diabetes(Y/N) | 3/43 | 25/68 | 0.010 | 0.212 | 16/62 | 12/49 | 0.902 | 0.144 | 16/82 | 12/29 | 0.087 | 0.204 |
CHD(Y/N) | 8/38 | 77/16 | <0.001 | <0.001 | 39/39 | 46/15 | 0.003 | 0.008 | 56/42 | 29/12 | 0.136 | 0.459 |
TC(mmol/l) | 4.44±0.99 | 4.50±1.18 | 0.735 | 0.285 | 4.41±1.20 | 4.57±0.99 | 0.401 | 0.625 | 4.46±1.16 | 4.53±1.02 | 0.762 | 0.082 |
TG(mmol/l) | 1.60±0.76 | 1.89±2.73 | 0.525 | 0.513 | 1.86±2.97 | 1.70±0.78 | 0.680 | 0.943 | 1.82±2.66 | 1.73±0.84 | 0.845 | 0.243 |
HDL-C(mmol/l) | 1.10±0.369 | 1.10±0.27 | 0.900 | 0.252 | 1.10±0.31 | 1.10±0.29 | 0.919 | 0.861 | 1.12±0.30 | 1.05±0.30 | 0.205 | 0.071 |
LDL-C(mmol/l) | 2.64±0.77 | 2.73±1.01 | 0.615 | 0.166 | 2.61±0.97 | 2.81±0.88 | 0.198 | 0.325 | 2.69±0.94 | 2.72±0.93 | 0.863 | 0.117 |
M: methylationed; U: unmethylationed; P-value*: adjusted for age, gender, smoking (smoker vs never smoker), lipid level, history of hypertension, and history of diabetes by Cox regression. P<0.05 is considered statistically significant.